In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

Pharmacological properties

isoxuprin is a peripheral vasodilator, an agonist of β-adrenergic receptors. Due to the stimulating effect on β-adrenergic receptors, isoxuprine reduces the tone of the smooth muscles of blood vessels, eliminates their spasm, improves peripheral and cerebral blood circulation and, accordingly, blood supply to tissues. exhibits a positive inotropic and chronotropic cardiac effect, as well as tocolytic effect. in in vitro and in vivo studies, isoxuprin inhibited spontaneous and oxytocin-induced uterine activity during labor. isoxuprin has a minor bronchodilator effect. in high doses, inhibits platelet aggregation and reduces blood viscosity.

Pharmacokinetics Isoxuprin is rapidly absorbed in the digestive tract. Metabolized by partial conjugation in the liver. When taken orally Cmax in plasma observed after 1 h. T½ the drug is about 1.25 hours. It is excreted mainly with urine, in a small amount - with feces.


Peripheral circulation disorders, including obliterating endarteritis, atherosclerosis obliterans, limb arteriosclerosis, diabetic angiopathy, disease and Raynauds syndrome.

Chronic cerebral vascular insufficiency in cerebral atherosclerosis.

Atherosclerosis of the retinal arteries.


For diseases accompanied by circulatory disorders, the drug should be used 10–20 mg 3-4 times a day after meals. the course of treatment is 2-3 months.


  • Hypersensitivity to the active substance or any other component of the drug; history of bleeding and hemorrhage; angina pectoris; arterial hypotension; use of the drug immediately after childbirth is contraindicated.

Side effects

From the cardiovascular system: tachycardia, increased heart rate, arterial hypotension, pain behind the sternum.

From the nervous system: dizziness.

From the gastrointestinal tract: dyspeptic disorders, nausea, vomiting.

On the part of the skin and subcutaneous tissue: skin rash.

General condition and disorders associated with the method of use of the drug: weakness, hot flashes.

From the immune system: in individuals with individual intolerance to any component of the drug, hypersensitivity reactions are possible.

special instructions

It is necessary to prescribe the drug with caution in the presence of tachycardia, hot flashes, blood clotting disorders, with glaucoma, in the acute phase of myocardial infarction and stroke.

During treatment with the drug, elderly patients should be careful to get out of bed, to avoid a sharp change in body position in order to prevent orthostatic hypotension.

The effect of the drug may be reduced in patients who smoke.

Do not drink alcoholic beverages during treatment with Suprilex.

Due to the risk of developing pulmonary edema in the mother and tachycardia in the fetus, Suprilex should not be used for premature birth and childbirth complicated by infection.

Use during pregnancy and lactation. Prescribing Suprilex to pregnant women is contraindicated. There is no data on the safety of isoxuprine during lactation, therefore, the use of the drug during lactation should be avoided.

Children. There is no data on the safe use of the drug in children, therefore the drug Suprilex should not be used in people under the age of 18 years.

The ability to influence the reaction rate when driving vehicles or other mechanisms. The drug may cause drowsiness or dizziness. In this case, it is necessary to avoid driving vehicles and working with complex mechanisms.

Special security measures. Do not exceed the dose and duration of treatment prescribed by your doctor.In case of adverse reactions during treatment with the drug, be sure to consult a doctor.


There is no data on the negative interaction of isoxuprine with other drugs. it is possible to enhance the vasodilating effect while using vasodilators used in cardiology.


Symptoms: tachycardia, palpitations, chest pain, decreased hell (collapse), dizziness, weakness, loss of consciousness, nausea, vomiting.

Treatment: symptomatic.

Storage conditions

At a temperature not exceeding 25 ° c.

Tags: Suprilex® [Isoxuprin]